Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
基本信息
- 批准号:7800882
- 负责人:
- 金额:$ 25.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-04-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAge related macular degenerationApoptosisApoptoticAutoimmunityB-Cell ActivationBindingBiologicalBiological AssayBiosensorCell LineCellsClinicalClinical TrialsComplementComplement 3 ConvertaseComplement ActivationComplement InactivatorsCytolysisDiscriminationDiseaseElementsEnzymesExcisionFunctional disorderGenerationsGoalsHost DefenseHousekeepingImmunityInfectionInfectious AgentInflammatory ResponseInjuryKineticsLeadLiver RegenerationMethodsModelingNeisseriaPlayPreventionProductionProperdinReagentRegulationReproductionResearch PersonnelRoleSideSperm-Ovum InteractionsSurfaceSurface Plasmon ResonanceT-LymphocyteTherapeuticTherapeutic AgentsThinkingTissuesalternative pathway complement C3 convertasebasedesignhuman diseaseimmune clearancemicrobialnew therapeutic targetnovelnovel strategiespathogenprogramsresearch studytissue regenerationtumor
项目摘要
DESCRIPTION (provided by applicant): Complement marks infectious agents for immune clearance or lysis, promotes the local inflammatory response, and facilitates B cell activation and Ab production. Complement is also active during apoptosis, reproduction, and tissue regeneration although the biological significance of its roles in these cases is unclear. On the negative side, complement is a principal cause of tissue damage in human diseases. While there are several first-generation complement inhibitors undergoing clinical trials, there remains a compelling need for novel complement-based reagents for clinical use. The C3 convertases are the primary enzymes of complement activation. Complement-related disease and injury can be traced both to inappropriate convertase assembly (e.g. autoimmunity), and to convertase regulator dysfunction (e.g. atypical HUS, age-related macular degeneration). The control of convertase activation and regulation is the key to therapeutic strategies for both the prevention of complement-related damage, and the promotion of complement activity towards pathogens, tumors, and other appropriate targets. Our long-range goals are to design new clinical approaches based on an understanding gained from studies of the C3 convertases. We have discovered that properdin binds directly to certain microbial surfaces where it initiates convertase assembly and complement activation. These findings specifically account for the critical role of properdin in the host defense against Neisseria infection, suggest that properdin likely plays a major role in the identification of other microbial targets, and support a model of complement activation in which properdin plays a much more prominent role than reflected in current thinking. We have also obtained evidence that properdin-directed complement activation plays a role in the programmed removal of undesirable cells (apoptosis). We believe that an intense examination of properdin-directed complement activation will lead to a new understanding of the mechanism and scope of complement activation in immunity and in cell and tissue-level housekeeping functions, and will result in novel therapeutic targets and strategies for the suppression and the guidance of complement-dependent destruction. To that end we propose experiments directed to the following specific aims: 1. Elucidate the kinetics and mechanism of properdin-directed complement activation. 2. Characterize the impact of "properdin-tagging" on nucleated cells and pathogens. 3. Define the structural elements that determine properdin in target recognition.
描述(由申请方提供):补体标记用于免疫清除或溶解的感染因子,促进局部炎症反应,并促进B细胞活化和Ab产生。补体在细胞凋亡、生殖和组织再生过程中也是活跃的,尽管其在这些情况下的作用的生物学意义尚不清楚。在负面方面,补体是人类疾病中组织损伤的主要原因。虽然有几种第一代补体抑制剂正在进行临床试验,但仍然迫切需要用于临床用途的新型补体基试剂。C3转化酶是补体激活的主要酶。补体相关疾病和损伤可追溯至不适当的转化酶组装(例如自身免疫)和转化酶调节功能障碍(例如非典型HUS、年龄相关性黄斑变性)。转化酶活化和调节的控制是预防补体相关损伤和促进补体对病原体、肿瘤和其他适当靶标的活性的治疗策略的关键。我们的长期目标是根据对C3转化酶研究的理解设计新的临床方法。我们已经发现备解素直接结合到某些微生物表面,在那里它启动转化酶组装和补体激活。这些发现特别说明备解素在宿主防御奈瑟氏菌感染中的关键作用,表明备解素可能在识别其他微生物靶标中起主要作用,并支持补体激活模型,其中备解素发挥的作用比目前的想法更为突出。我们还获得了备解素导向的补体激活在程序性去除不需要的细胞(凋亡)中起作用的证据。我们相信,对备解素介导的补体激活的深入研究将导致对补体激活在免疫中以及在细胞和组织水平的管家功能中的机制和范围的新理解,并将导致用于抑制和指导补体依赖性破坏的新的治疗靶点和策略。为此,我们提出了针对以下具体目标的实验:1。阐明备解素介导的补体激活的动力学和机制。2.表征“备解素标记”对有核细胞和病原体的影响。3.定义决定备解素在靶点识别中的结构要素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DENNIS EMIL HOURCADE其他文献
DENNIS EMIL HOURCADE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DENNIS EMIL HOURCADE', 18)}}的其他基金
Cellular Models of a Monogenic Small Vessel Disease of the Brain
脑单基因小血管疾病的细胞模型
- 批准号:
10307638 - 财政年份:2020
- 资助金额:
$ 25.83万 - 项目类别:
Analysis of Complement Activation and Regulation by Mass Cytometry
通过质谱流式细胞术分析补体激活和调节
- 批准号:
9235239 - 财政年份:2016
- 资助金额:
$ 25.83万 - 项目类别:
Characterization/bioinformatics-modeling of nanoparticle:complement interactions
纳米粒子的表征/生物信息学建模:补体相互作用
- 批准号:
8323416 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Characterization/bioinformatics-modeling of nanoparticle:complement interactions
纳米粒子的表征/生物信息学建模:补体相互作用
- 批准号:
8068114 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Characterization/bioinformatics-modeling of nanoparticle:complement interactions
纳米粒子的表征/生物信息学建模:补体相互作用
- 批准号:
8150949 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
8070077 - 财政年份:2010
- 资助金额:
$ 25.83万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
6616462 - 财政年份:2003
- 资助金额:
$ 25.83万 - 项目类别:
COMPLEMENT CONVERTASE: ASSEMBLY, FUNCTION AND REGULATION
补充转化酶:组装、功能和调节
- 批准号:
8437634 - 财政年份:2003
- 资助金额:
$ 25.83万 - 项目类别:
COMPLEMENT CONVERTASE: ASSEMBLY, FUNCTION AND REGULATION
补充转化酶:组装、功能和调节
- 批准号:
8897952 - 财政年份:2003
- 资助金额:
$ 25.83万 - 项目类别:
Complement Convertase: Assembly, Function and Regulation
补体转化酶:组装、功能和调节
- 批准号:
8055493 - 财政年份:2003
- 资助金额:
$ 25.83万 - 项目类别:
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 25.83万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 25.83万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 25.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 25.83万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 25.83万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 25.83万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 25.83万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 25.83万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 25.83万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 25.83万 - 项目类别: